PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsExtreme number of mutations may impart tumour drug resistance

BioNews

Extreme number of mutations may impart tumour drug resistance

Published 16 November 2015 posted in News and appears in BioNews 828

Author

Paul Waldron

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Over 100 million genetic changes have been found in a single tumour, according to a new study...

Over 100 million genetic changes have been found in a single tumour, according to a new study.

Scientists at the University of Chicago and the Beijing Institute of Genomics have used rigorous genetic analysis techniques to conclude that cancer cells may have many more mutations than previously thought. Mutations in cancer cells are associated with drug resistance (see BioNews 827), and the authors say that the findings could explain how and why cancers develop resistance to treatment.

Chung-I Wu, professor of ecology and evolution at the University of Chicago, and one of the study's lead authors, said: 'With 100 million mutations, each capable of altering a protein in some way, there is a high probability that a significant minority of tumour cells will survive, even after aggressive treatment.

'In a setting with so much diversity, those cells could multiply to form new tumours, which would be resistant to standard treatments.'

In the study, published in PNAS, scientists took a slice of a single human liver tumour, about 35mm in diameter. They took 286 samples of around 20,000 cells, each from different places in the slice, and analysed the genetic code to find differences from the genomes of healthy cells.

From their results, they estimated that over 100 million mutations were present in the tumour — far more than previous estimates of up to 20,000 generally thought to exist in a single cancer. These mutations were present in 'coding sequences', which tell the cell how to assemble proteins.

They also found that at least 99 percent of the mutations were very rare in the tumour, present in the genomes of fewer than 100 cells. These cells were often in close proximity to each other.

The group also says that its findings indicate that mutations in tumour cells arise and spread in a more random way than prevailing theories suppose. Previously, it has been assumed that when a mutation appears which helps the cancer to survive, the cells carrying this mutation spread through a tumour by out-competing neighbouring cells.

However, this process would be expected to reduce the genetic diversity of a population, as cells with less suitable mutations would be replaced, inconsistent with the large number of mutations found in this study. The authors write that the small groups of cells expressing rare mutations are 'competing mostly with themselves' and cannot spread through the structure of a solid tumour.

Previous studies have shown that survival rates are reduced if a cancer is very genetically diverse. The authors conclude that their findings show that even small tumours could have very high genetic diversity, and write that this 'suggests a need to re-evaluate treatment strategies.'

Related Articles

PET BioNews
News
8 November 2019 • 2 minutes read

Cancer cells limit DNA repair to overcome treatment

by Dr Laura Riggall

Colorectal cancer cells increase the rate of mutations and impair DNA repair in their genomes to become more resistant to targeted therapies, a new study suggests...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
15 May 2017 • 1 minute read

Gene associated with treatment-resistant ovarian cancers identified

by Chris Baldacci

Scientists have discovered a gene called FGF1 which is highly active in aggressive and advanced ovarian cancers...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 May 2017 • 2 minutes read

Genes account for half of testicular cancer risk

by Meetal Solanki

Gene mutations may account for as much of half the risk of developing testicular cancer, a study has suggested...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
30 November 2015 • 2 minutes read

Genes essential to human life — and cancer — identified

by Dr Jane Currie

Scientists have used genome-editing technology to identify a core set of 1580 genes that are essential to human life...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 November 2015 • 2 minutes read

Gene mutations can predict prostate cancer drug resistance

by Kirsty Oswald

Researchers have identified the genetic mutations that drive resistance to the hormone therapy abiraterone in patients with advanced prostate cancer...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 November 2015 • 1 minute read

Liquid biopsy could track cancer progress in real time

by Ayala Ochert

Scientists say it may be possible to track the progress of cancer — and cancer treatment — in real time from fragments of tumour DNA that are shed into the bloodstream...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
1 February 2013 • 2 minutes read

Cancer genetics: plans for London-based Tumour Profiling Unit unveiled

by David Gerard O'Rourke

The planned Tumuor Profiling Unit at The Institute for Cancer Research, London will focus on sequencing the DNA of cancer tumours to help diagnose and monitor different types of cancer, and to also identify those more likely to respond to particular treatments....

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Scientists discover sperm can 'slither'

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

15 August 2022 • 2 minutes read

Call to end ban on HIV-positive partner gamete 'donation'

15 August 2022 • 2 minutes read

Melanoma invades new tissues using nerve cell gene

15 August 2022 • 2 minutes read

Exceeding alcohol limits could damage DNA and accelerate ageing

15 August 2022 • 2 minutes read

Blood cell gene mutations affect mitochondria, increasing cardiovascular disease risk

15 August 2022 • 2 minutes read

Jumping gene helps immune system fight viruses

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856